Publications by authors named "M Zecchin"
Article Synopsis
- A study analyzed long-term outcomes in 1,184 patients with implantable cardioverter defibrillators (ICDs) to compare the risks of appropriate interventions and overall survival between those with ischemic heart disease (IHD) and non-ischemic heart disease (NIHD).
- Findings revealed that all-cause mortality was significantly higher in patients with IHD (60%) compared to those with NIHD (43%), but the rate of appropriate ICD interventions did not differ significantly over ten years (34% for IHD vs. 40% for NIHD).
- Additionally, within NIHD, certain types of heart disease like valvular disease and chemotherapy-related dilated cardiomyopathy showed higher mortality rates, while inappropriate
Background: Patients with nonischemic dilated cardiomyopathy (DCM), severe left ventricular (LV) dysfunction, and complete left bundle branch block benefit from cardiac resynchronization therapy (CRT). However, a large heterogeneity of response to CRT is described. Several predictors of response to CRT have been identified, but the role of the underlying genetic background is still poorly explored.
View Article and Find Full Text PDFArticle Synopsis
- - Myotonic dystrophy is a genetic condition that affects multiple systems in the body, including the nervous and cardiovascular systems.
- - The Italian Neuro-Cardiology Network (INCN-RNC) is a collaboration between neurology and cardio-arrhythmology units aimed at improving patient care.
- - INCN helps establish integrated teams in Neuromuscular Disease Centers to better manage the cardiovascular issues associated with myotonic dystrophy type 1 (MD1).
At the beginning of the COVID-19 emergency, non-urgent surgical procedures had to be deferred, but also emergencies were reduced. To assess the global trend of pacemaker (PM) and implantable cardiac-defibrillator (ICD) procedures performed in Italy before, during, and after the first COVID-19 emergency, all the Italian hospital discharge records related to PM/ICD procedures performed between 2012 and 2021, sent to the National Institute of Health, were reviewed. Compared to 2019, in 2020, there was a reduction of first PM implants (52,216 to 43,962, -16%; p < 0.
View Article and Find Full Text PDFBackground: There are limited data on implantable-cardioverter-defibrillator (ICD) implantation after ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (pPCI). Therefore, we evaluated when and how frequently an ICD is implanted after pPCI, the rate of appropriate ICD interventions, and predictors of ICD implantation.
Methods: We analyzed STEMI patients treated with pPCI at the University Hospital of Trieste, Italy, between January 2010 and December 2019.